The teenage patient with a developmental epileptic encephalopathy (DEE) sits at the intersection of pediatric epilepsy and adult epilepsy. They are a unique group which have often missed the extensive genetic evaluations that pediatric epileptologists do now for our young children with a DEE. They are transitioning to an adult world that are not used to handling them since they carry mutations only recently discovered and may have not survived into adulthood in the past. This webinar will discuss some of these unique problems with a panel of experienced pediatric epileptologists that do extensive care of these patients.
Learning ObjectivesUpon completion of this activity, participants will be able to:
Anup D. Patel, MD, FAAN, FAES, FCNS is the Associate Chief Quality Officer in the Center for Clinical Excellence at Nationwide Children’s Hospital. He is a Professor in Clinical Pediatrics and Neurology at the Ohio State University College of Medicine. He is board certified in neurology with special qualifications in child neurology. In addition, he is board certified in epilepsy and clinical neurophysiology. He is the Chair of the Quality Committee for the American Academy of Neurology (AAN). He is a member of the Board of Directors for the AAN Institute. He has interests in child neurology, pediatric epilepsy, and quality improvement. Clinically, he sees patients with non-surgical treatment resistant epilepsy. Academically, he has over 100 peer reviewed publications.